IL10 and inflammatory bowel disease: There was significantly higher score in WT B group compared with ManLAM‐WT B group (*P < .05), suggesting that the higher level of IL‐10 produced by ManLAM‐treated B cells facilitated to ameliorate intestinal inflammation in the mice with IBD (Figure 3B).